ATTR-CM

·MeSH: Amyloid Neuropathies, Familial

5 drugs in development·4 companies·2 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
attruby	BridgeBio Pharma, Inc. (BBIO)
supplemental new drug	ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Phase 3(2)

Drug	Company
coramitug	PROTHENA CORP PUBLIC LTD CO (PRTA)
eplontersen	ASTRAZENECA PLC (AZN)

Phase 2(1)

Drug	Company
alxn2220	ASTRAZENECA PLC (AZN)

BioSniper tracks 5 drugs in development for ATTR-CM across 4 companies.

There are 2 clinical trials targeting ATTR-CM tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.